203 related articles for article (PubMed ID: 21596442)
1. Time to rehospitalization in patients with schizophrenia discharged on first generation antipsychotics, non-clozapine second generation antipsychotics, or clozapine.
Werneck AP; Hallak JC; Nakano E; Elkis H
Psychiatry Res; 2011 Aug; 188(3):315-9. PubMed ID: 21596442
[TBL] [Abstract][Full Text] [Related]
2. Antipsychotic monotherapy and adjuvant psychotropic therapies in schizophrenia patients: effect on time to readmission.
Valevski A; Gilat Y; Olfson M; Benaroya-Milshtein N; Weizman A
Int Clin Psychopharmacol; 2012 May; 27(3):159-64. PubMed ID: 22466059
[TBL] [Abstract][Full Text] [Related]
3. Rehospitalization rates of patients recently discharged on a regimen of risperidone or clozapine.
Conley RR; Love RC; Kelly DL; Bartko JJ
Am J Psychiatry; 1999 Jun; 156(6):863-8. PubMed ID: 10360124
[TBL] [Abstract][Full Text] [Related]
4. Time to rehospitalization of clozapine versus risperidone in the naturalistic treatment of comorbid alcohol use disorder and schizophrenia.
Kim JH; Kim D; Marder SR
Prog Neuropsychopharmacol Biol Psychiatry; 2008 May; 32(4):984-8. PubMed ID: 18262321
[TBL] [Abstract][Full Text] [Related]
5. Changes in neuroendocrine and metabolic hormones induced by atypical antipsychotics in normal-weight patients with schizophrenia.
Popovic V; Doknic M; Maric N; Pekic S; Damjanovic A; Miljic D; Popovic S; Miljic N; Djurovic M; Jasovic-Gasic M; Dieguez C; Casanueva FF
Neuroendocrinology; 2007; 85(4):249-56. PubMed ID: 17570902
[TBL] [Abstract][Full Text] [Related]
6. Rehospitalization rates of chronically ill schizophrenic patients discharged on a regimen of risperidone, olanzapine, or conventional antipsychotics.
Rabinowitz J; Lichtenberg P; Kaplan Z; Mark M; Nahon D; Davidson M
Am J Psychiatry; 2001 Feb; 158(2):266-9. PubMed ID: 11156809
[TBL] [Abstract][Full Text] [Related]
7. [Intervals between hospitalisations in schizophrenia patients under antipsychotics in depot-form versus oral second generation antipsychotics].
Gutwinski S; Müller P; Koller M
Psychiatr Prax; 2007 Sep; 34(6):289-91. PubMed ID: 17806015
[TBL] [Abstract][Full Text] [Related]
8. Comparison of time to rehospitalization among schizophrenic patients discharged on typical antipsychotics, clozapine or risperidone.
Lin CH; Lin SC; Chen MC; Wang SY
J Chin Med Assoc; 2006 Jun; 69(6):264-9. PubMed ID: 16863012
[TBL] [Abstract][Full Text] [Related]
9. Three-year antipsychotic effectiveness in the outpatient care of schizophrenia: observational versus randomized studies results.
Haro JM; Suarez D; Novick D; Brown J; Usall J; Naber D;
Eur Neuropsychopharmacol; 2007 Mar; 17(4):235-44. PubMed ID: 17137759
[TBL] [Abstract][Full Text] [Related]
10. Predictors for starting depot administration of risperidone in chronic users of antipsychotics.
Vehof J; Postma MJ; Bruggeman R; De Jong-Van Den Berg LT; Van Den Berg PB; Stolk RP; Burger H
J Clin Psychopharmacol; 2008 Dec; 28(6):625-30. PubMed ID: 19011430
[TBL] [Abstract][Full Text] [Related]
11. Choosing antipsychotic maintenance therapy--a naturalistic study.
Tavcar R; Dernovsek MZ; Zvan V
Pharmacopsychiatry; 2000 Mar; 33(2):66-71. PubMed ID: 10761822
[TBL] [Abstract][Full Text] [Related]
12. Rehospitalization rates of patients with schizophrenia discharged on haloperidol, risperidone or clozapine.
Castro AP; Elkis H
Braz J Psychiatry; 2007 Sep; 29(3):207-12. PubMed ID: 17891257
[TBL] [Abstract][Full Text] [Related]
13. Does switching to another antipsychotic in patients with clozapine-associated granulocytopenia solve the problem? Case series of 18 patients.
Coşar B; Taner ME; Eser HY; Altınöz AE; Tarhan R
J Clin Psychopharmacol; 2011 Apr; 31(2):169-73. PubMed ID: 21346615
[TBL] [Abstract][Full Text] [Related]
14. Incidence of extrapyramidal symptoms and tardive dyskinesia in schizophrenia: thirty-six-month results from the European schizophrenia outpatient health outcomes study.
Novick D; Haro JM; Bertsch J; Haddad PM
J Clin Psychopharmacol; 2010 Oct; 30(5):531-40. PubMed ID: 20814320
[TBL] [Abstract][Full Text] [Related]
15. Risperidone use at a state hospital: a clinical audit 2 years after the first wave of risperidone prescriptions.
Chengappa KN; Sheth S; Brar JS; Parepally H; Marcus S; Gopalani A; Palmer A; Baker RW; Schooler NR
J Clin Psychiatry; 1999 Jun; 60(6):373-8. PubMed ID: 10401915
[TBL] [Abstract][Full Text] [Related]
16. A nationwide cohort study of oral and depot antipsychotics after first hospitalization for schizophrenia.
Tiihonen J; Haukka J; Taylor M; Haddad PM; Patel MX; Korhonen P
Am J Psychiatry; 2011 Jun; 168(6):603-9. PubMed ID: 21362741
[TBL] [Abstract][Full Text] [Related]
17. One-year rehospitalization rates of patients discharged on atypical versus conventional antipsychotics.
Patel NC; Dorson PG; Edwards N; Mendelson S; Crismon ML
Psychiatr Serv; 2002 Jul; 53(7):891-3. PubMed ID: 12096177
[TBL] [Abstract][Full Text] [Related]
18. Rehospitalization risk with second-generation and depot antipsychotics.
Conley RR; Kelly DL; Love RC; McMahon RP
Ann Clin Psychiatry; 2003 Mar; 15(1):23-31. PubMed ID: 12839430
[TBL] [Abstract][Full Text] [Related]
19. Quality of life in the long-term treatment and the role of second-generation antipsychotics.
Mohr P
Neuro Endocrinol Lett; 2007 Feb; 28 Suppl 1():117-33. PubMed ID: 17262004
[TBL] [Abstract][Full Text] [Related]
20. Diffusion of a new drug: a comparative analysis of adoption, treatment complexity, and persistence of risperidone long-acting injectable therapy in the Netherlands.
Pechlivanoglou P; Vehof J; van Agthoven M; de Jong-van den Berg LT; Postma MJ
Clin Ther; 2010 Jan; 32(1):108-18. PubMed ID: 20171417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]